HAMP and metabolic dysfunction-associated steatotic liver disease: The results of the present study are supported by previous research indicating that in morbidity obese women with non-alcoholic fatty liver disease, hepatic expression of hepcidin mRNA is significantly greater than in obese women with normal liver [50].